abstract |
The present invention relates to the use of certain doses of 1,2,4-oxadiazole benzoic acid compounds in the treatment or prophylaxis of diseases associated with nonsense mutations, Lt; / RTI > In particular, the present invention relates to the use of 3- [5- (2-fluorophenyl) - [1,2,4] oxadiazol-3-yl] -benzoic acid in mammals with a disease associated with nonsense mutation To a particular dosage and administration regimen. |